Business

In this article AMGN LLY NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Pavlo Gonchar | Lightrocket | Getty Images Amgen‘s stock rose more than 12% on Friday after the drugmaker teased positive initial data on its experimental weight loss injection.  That fueled investor concerns about new competition in the rapidly growing weight loss drug industry,

In this article CVS Follow your favorite stocksCREATE FREE ACCOUNT CVS Health on Wednesday reported first-quarter revenue and adjusted earnings that missed expectations and slashed its full-year profit outlook, citing higher medical costs that are dogging the U.S. insurance industry. Shares of the company closed more than 16% lower on Wednesday, and were headed for

In this article W Follow your favorite stocksCREATE FREE ACCOUNT The Wayfair app on a smartphone arranged in Hastings-on-Hudson, New York. Tiffany Hagler-Geard | Bloomberg | Getty Images Wayfair’s sales slid during its first quarter, but the online furniture retailer reduced its losses after cutting 13% of its workforce at the start of the year,

In this article PARA Follow your favorite stocksCREATE FREE ACCOUNT Shari Redstone, Paramount Global, attends the Allen & Co. Media and Technology Conference in Sun Valley, Idaho, July 11, 2023. David A. Grogan | CNBC Sony Pictures and private equity firm Apollo Global Management have sent a letter to the Paramount Global board expressing interest

In this article MRNA Follow your favorite stocksCREATE FREE ACCOUNT Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Thursday posted a narrower-than-expected loss for the first quarter as the company’s cost-cutting efforts took hold and sales of its Covid vaccine, its only commercially available product, topped estimates.  The results come as Moderna inches closer

In this article CVNA Follow your favorite stocksCREATE FREE ACCOUNT Vehicles are seen on display at a Carvana dealership in Austin, Texas, on Feb. 20, 2023. Brandon Bell | Getty Images Shares of Carvana popped more than 30% during after-hours trading Wednesday after the automaker reported record quarterly results and turned a profit during the

In this article SBUX CMG MCD QSR-CA YUM Follow your favorite stocksCREATE FREE ACCOUNT A Starbucks logo is seen as members and supporters of Starbucks Workers United protest outside of a Starbucks store in Dupont Circle, Washington, D.C., on Nov. 16, 2023. Kevin Dietsch | Getty Images It’s finally here: the long-predicted consumer pullback. Starbucks

In this article JNJ Follow your favorite stocksCREATE FREE ACCOUNT Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer, pending approval of the claimants. Those cases have for decades caused

In this article NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023.  Lee Smith | Reuters The Federal Trade Commission on Tuesday said it is challenging hundreds of alleged “junk” patents held by pharmaceutical companies for 20 brand-name drugs,

In this article SBUX Follow your favorite stocksCREATE FREE ACCOUNT A Starbucks coffee shop in Amsterdam. Nicolas Economou | Nurphoto | Getty Images Starbucks on Tuesday reported weaker-than-expected quarterly earnings and revenue, fueled by a surprise decline in same-store sales. “In a highly challenged environment, this quarter’s results do not reflect the power of our

In this article KO Follow your favorite stocksCREATE FREE ACCOUNT A Coca-Cola building in Zagreb, Croatia, Nov. 8, 2023. Denis Lovrovic | AFP | Getty Images Coca-Cola reported its first-quarter earnings before the bell Tuesday. Here’s what the company reported compared with what Wall Street analysts surveyed by LSEG were expecting: Earnings per share: 72

In this article BMY Follow your favorite stocksCREATE FREE ACCOUNT Jonathan Raa | Nurphoto | Getty Images A federal judge in New Jersey on Monday rejected Johnson & Johnson‘s and Bristol Myers Squibb‘s legal challenges to the Biden administration’s Medicare drug-price negotiations, ruling that the program is constitutional.  The decision is another win for the